Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07052539 · ClinicalTrials.gov registry record
The Epidemiology and Pathophysiology of Kidney Disease in HFpEF With Obesity
A clinical trial of Chronic Kidney Disease and Heart Failure With Preserved Ejection Fraction (HFPEF), sponsored by University of Mississippi Medical Center.
- Recruiting
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT07052539: Recruiting study of Chronic Kidney Disease and Heart Failure With Preserved Ejection Fraction (HFPEF), sponsored by University of Mississippi Medical Center.
NCT07052539 is a study of Chronic Kidney Disease and Heart Failure With Preserved Ejection Fraction (HFPEF) that is actively recruiting participants, run by University of Mississippi Medical Center. The registered enrollment target is 60 participants, below the 3,206-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07052539, a study of Chronic Kidney Disease and Heart Failure With Preserved Ejection Fraction (HFPEF), is actively recruiting participants, sponsored by University of Mississippi Medical Center.
- RECRUITING
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study wants to learn about Chronic Kidney Disease (CKD) with Obesity, and Heart Failure with preserved Ejection Fraction (HFpEF) and better ways to evaluate these diseases. HFpEF means that the heart is not able to fill properly with blood while it is resting so the amount of blood pumped out to the body is less than it would be if it was filling properly. The study is being done to describe the differences in how the kidneys handle protein and salt in participants with HFpEF and obesity compared to healthy persons.
Conditions Studied
Interventions
- OTHER High protein and sodium meal
Study Locations (1)
Mississippi
- University of Mississippi Medical Center - Jackson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2022-07-22 |
| Est. Completion | 2026-07-31 |
What NCT07052539 shows while recruiting
NCT07052539 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 3,206-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (98% lower).
The record links to 3 conditions, with Chronic Kidney Disease appearing as the primary indexed condition, and to 1 intervention - of which High protein and sodium meal is the first listed.
NCT07052539 reports a single indexed study location in Mississippi.
Frequently Asked Questions
What is clinical trial NCT07052539 about?
NCT07052539 is a clinical study titled "The Epidemiology and Pathophysiology of Kidney Disease in HFpEF With Obesity". This research study wants to learn about Chronic Kidney Disease (CKD) with Obesity, and Heart Failure with preserved Ejection Fraction (HFpEF) and better ways to evaluate these diseases. HFpEF means that the heart is not able to fill properly with blood while it is resting so the amount of blood pum...
What is the current status of trial NCT07052539?
This trial is currently recruiting. The enrollment target is 60 participants. The study started on 2022-07-22. Estimated completion is 2026-07-31.
What conditions does trial NCT07052539 study?
This clinical trial studies the following conditions: Chronic Kidney Disease, Heart Failure With Preserved Ejection Fraction (HFPEF), Obesity (Disorder).
What interventions are being tested in trial NCT07052539?
The interventions under investigation include: High protein and sodium meal (OTHER).
Who is sponsoring clinical trial NCT07052539?
This trial is sponsored by University of Mississippi Medical Center, which has 96 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07052539 being conducted?
This trial has 1 study location across Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Kidney Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07052539's enrollment target sits among peer trials
60 69th of 101 higher than 31 of 101 other Chronic Kidney Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Kidney Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD
RECRUITING · Phase 2
-
Patient-driven Management of BP in CKD
RECRUITING · Phase 3
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Pivotal Study of the Velocity™ pAVF System
RECRUITING · NA
-
Safety of Short-course of NSAIDs in Pediatric Patients With CKD
RECRUITING · Phase 4
-
Intensive Patient Referral and Education Program Prior to Renal Replacement Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI